November 25, 2024 – Henry Schein, Inc. has introduced that it has signed an settlement to amass Acentus, a nationwide medical provider specializing within the provide of steady glucose screens (CGMs).

The Acentus transaction follows Henry Schein's acquisition of Prism Medical Merchandise, LLC in 2021 and Protect Healthcare and Mini Pharmacy in 2023, strengthening the corporate's strategic dedication to the house healthcare medical system market. Henry Schein's dwelling care medical merchandise platform will now have an annual income base of roughly $350 million.

With annual revenues of roughly $35 million, Acentus is headquartered in Tampa, Florida. Henry Schein expects the transaction to be impartial to non-GAAP earnings per share in 2024 and to extend thereafter. The closing is topic to straightforward closing circumstances and is anticipated to shut within the first quarter of 2025. Monetary phrases weren’t disclosed.

Proceed studying